galantamine has been researched along with curcumin in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 4 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ji, S; Li, K; Li, Z; Liang, W; Qiao, X; Song, W; Tang, S; Wang, Q; Wang, Y; Ye, M; Yu, S; Zhou, D | 1 |
| Hoda, N; Jameel, E; Jayaram, B; Kumar, J; Maqbool, M; Meena, P; Mobashir, M; Shandilya, A; Singh, A; Tiwari, M | 1 |
| Kang, Y; Li, Q; Li, Y; Tu, Y; Wu, C; Zhu, C | 1 |
| Ji, J; Peng, Y; Rakesh, KP; Wang, S; Xu, M; Zhu, L | 1 |
| Amoroso, R; Carradori, S; De Filippis, B; Fantacuzzi, M | 1 |
| Atanasova, M; Atanasova, T; Doytchinova, I; Ivanov, S; Konstantinov, S; Lukarski, A; Philipova, I; Stavrakov, G; Zheleva, D; Zhivkova, ZD | 1 |
| Bhanuprakash, K; Chitumalla, RK; Karthikraj, R; Nagaveni, V; Prabhakar, S; Vairamani, M | 1 |
| Atanasova, M; Doumanov, J; Doytchinova, I; Mladenova, K; Petrova, S; Philipova, I; Stavrakov, G | 1 |
2 review(s) available for galantamine and curcumin
| Article | Year |
|---|---|
Triazole derivatives as inhibitors of Alzheimer's disease: Current developments and structure-activity relationships.
Topics: Acetylcholinesterase; Alzheimer Disease; Butyrylcholinesterase; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Humans; Molecular Structure; Neuroprotective Agents; Structure-Activity Relationship; Triazoles | 2019 |
Resveratrol-based compounds and neurodegeneration: Recent insight in multitarget therapy.
Topics: Humans; Neurodegenerative Diseases; Polyphenols; Resveratrol; Stilbenes; Structure-Activity Relationship | 2022 |
6 other study(ies) available for galantamine and curcumin
| Article | Year |
|---|---|
Bioactive Constituents of Glycyrrhiza uralensis (Licorice): Discovery of the Effective Components of a Traditional Herbal Medicine.
Topics: Acetylcholinesterase; Animals; Carbon Tetrachloride; Drugs, Chinese Herbal; Glycyrrhiza; Glycyrrhiza uralensis; GPI-Linked Proteins; Hep G2 Cells; Humans; Influenza A Virus, H1N1 Subtype; Lipopolysaccharides; Liver; Macrophages; MCF-7 Cells; Medicine, Traditional; Mice; Molecular Structure; Monophenol Monooxygenase; NF-kappa B; Nitric Oxide; Nuclear Magnetic Resonance, Biomolecular; Plant Roots; Plants, Medicinal; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Pyrrolizidine Alkaloids; Rhizome; Structure-Activity Relationship | 2016 |
Synthesis and screening of triazolopyrimidine scaffold as multi-functional agents for Alzheimer's disease therapies.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Butyrylcholinesterase; Cell Line, Tumor; Cell Survival; Chemistry Techniques, Synthetic; Cholinesterase Inhibitors; Drug Evaluation, Preclinical; Humans; Kinetics; Molecular Docking Simulation; Peptide Fragments; Protein Aggregates; Protein Conformation; Pyrimidines | 2016 |
Bioactivity-guided identification of flavonoids with cholinesterase and β-amyloid peptide aggregation inhibitory effects from the seeds of Millettia pachycarpa.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Butyrylcholinesterase; Cholinesterase Inhibitors; Flavonoids; Kinetics; Millettia; Plant Extracts; Seeds; Structure-Activity Relationship | 2019 |
Galantamine-Curcumin Hybrids as Dual-Site Binding Acetylcholinesterase Inhibitors.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Binding Sites; Blood-Brain Barrier; Cell Line; Cholinesterase Inhibitors; Combinatorial Chemistry Techniques; Curcumin; Galantamine; Humans; Mice; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship | 2020 |
Gas-phase basicity and proton affinity measurements of Alzheimer's disease drugs by the extended kinetic method and a theoretical investigation.
Topics: Alzheimer Disease; Curcumin; Galantamine; Humans; Neuroprotective Agents; Protons; Rivastigmine; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2020 |
A Galantamine-Curcumin Hybrid Decreases the Cytotoxicity of Amyloid-Beta Peptide on SH-SY5Y Cells.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Antineoplastic Agents; Antioxidants; Cholinesterase Inhibitors; Curcumin; Cytoprotection; Galantamine; Humans; Neuroblastoma; Protective Agents; Tumor Cells, Cultured | 2021 |